| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Executive Chairman | Director
1 company
Richard W Pascoe last filed a Form 4 in March 2023, as Chief Executive Officer at ZVRA. Richard W Pascoe's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Richard W Pascoe a middling insider score of 57/100, based on 4 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +4.4%.
At the last filing, the largest reported position was 29,973 shares of ZVRA. Net of sales, the ZVRA filings show accumulation of 36,000 shares.
Richard W Pascoe has 17 Form 4 filings on record from August 2015 to March 2023, all as Chief Executive Officer at Zevra Therapeutics (ZVRA), 2015–2023.
The 25 reported transactions were 13 open-market purchases, 10 option or other derivative awards and 2 stock awards.
Counted by filing, the open-market trades come to 5 purchases worth about $136K and no sales.
The largest open-market purchase was 9,500 shares of ZVRA at an average $5.44 on January 13, 2023, about $52K. Twelve months later ZVRA was up 7%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | ZVRA Zevra Therapeutics, Inc. | Chief Executive Officer | Buy | 10,000 | $4.20 | $41,978.00 | +50.1% | +27.3% | +43.5% | |
| Jan 13, 2023 | ZVRA Zevra Therapeutics, Inc. | Chief Executive Officer | Buy | 9,500 | $5.44 | $51,679.05 | +90.7% | +13.9% | +7.2% | |
| May 18, 2022 | ZVRA Zevra Therapeutics, Inc. | Executive Chairman | Buy | 5,000 | $4.92 | $24,607.59 | +152.2% | +16.0% | +6.1% | |
| Nov 30, 2021 | ZVRA Zevra Therapeutics, Inc. | Executive Chairman | Buy | 1,500 | $7.88 | $11,822.10 | +84.0% | -24.3% | -39.2% | |
| Aug 18, 2020 | ZVRA Zevra Therapeutics, Inc. | Director | Buy | 10,000 | $0.64 | $6,351.80 | +53.8% | - | - |